InDex Pharmaceuticals Holding AB (publ) announces Nomination Committee and financial reporting dates for 2018

November 16, 2017 – InDex Pharmaceuticals Holding AB (publ) today announced the composition of the Nomination Committee for the 2018 Annual General Meeting, which will be held on Thursday May 24, 2018. The responsibility of the Nomination Committee is to present to the 2018 Annual General Meeting  proposals regarding election of the Chairman of the Board and other members of the Board, fees and any other remuneration to the members of the Board as well as election and remuneration of the auditor.

InDex Pharmaceuticals will participate in the European Crohn’s and Colitis Organisation (ECCO) Congress

January 23, 2017 – InDex Pharmaceuticals Holding AB (publ) today announced that the company will have two posters at the 12th congress of the European Crohn’s and Colitis Organisation (ECCO). The ECCO congress is the largest congress in the world with a specific focus on inflammatory bowel disease (IBD). The congress is held in Barcelona, Spain on February 15-18, 2017.

Investor contact

Peter Zerhouni
Peter Zerhouni
+46 8 122 038 50